Potential of Novel EPO Derivatives in Limb Ischemia

<table>Schematic representation of the structure of erythropoietin receptor (EPOR) and beta-common receptor (CD131) on the left and the right hand side, respectively. *Based on Brines et al. [<a href="../#B20">29</a>]. JAK-2 stands for Janus family Tyrosine Protein Kinase 2.</table>

Cardiology Research and Practice

fig2

Figure 2

Figure 2: Potential of Novel EPO Derivatives in Limb Ischemia 